Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 804.00M | £ 1.21B | £ 1.63B | £ 1.57B | £ 1.07B |
Total Assets | £ 9.48B | £ 10.68B | £ 10.17B | £ 9.98B | £ 9.88B |
Total Debt | £ 2.30B | £ 2.21B | £ 2.19B | £ 2.05B | £ 2.10B |
Net Debt | £ 1.49B | £ 1.01B | £ 561.00M | £ 478.00M | £ 1.03B |
Total Liabilities | £ 4.91B | £ 5.34B | £ 5.17B | £ 5.18B | £ 5.05B |
Stockholders Equity | £ 4.57B | £ 5.33B | £ 4.99B | £ 4.80B | £ 4.83B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |